Background
On February 11, 2023, Dan Shuler, a miner-bolter, suffered a severe crush injury when a rock fell from above and struck his head, neck, and spine. The claim was found compensable for unspecified head injury and cervical strain. Over the following months, Shuler received physical therapy and underwent multiple imaging studies and procedures, including trigger-point injections and radiofrequency ablation, all of which provided only temporary relief from persistent headaches.
In September 2024, Dr. Manish Ranjan, a neurosurgeon at WVU, recommended an occipital nerve stimulator (ONS) trial to treat Shuler’s chronic head pain. On October 29, 2024, the claim administrator denied the authorization, reasoning that cervicogenic headaches were not a compensable diagnosis in the original claim. Shuler protested the denial to the Workers’ Compensation Board of Review.
The Board reversed the administrator’s decision on September 12, 2025, finding that ONS treatment was reasonable and necessary for Shuler’s compensable unspecified head injury. The employer appealed to the Intermediate Court of Appeals.
The Court’s Holding
The court affirmed the Board’s decision, holding that the ONS trial was a reasonable and necessary treatment for Shuler’s compensable head injury. The court rejected the employer’s argument that headaches are not compensable when the original claim was for “unspecified head injury,” reasoning that it is reasonable to conclude that headaches naturally result from head trauma and thus fall within the compensable injury.
The court emphasized that both treating physicians—Dr. Ebbert (neurologist) and Dr. Ranjan (neurosurgeon)—supported the ONS trial. The employer’s reliance on Dr. Mukkamala’s March 2024 opinion that no further treatment was needed was undercut by the fact that Dr. Mukkamala himself had recommended additional work conditioning treatment. Importantly, Dr. Ebbert explicitly recommended neurosurgical evaluation for possible ONS, directly addressing the disputed treatment.
Applying the deferential “clearly wrong” standard of review—which presumes an agency’s actions valid if supported by substantial evidence or rational basis—the court found the Board’s decision adequately supported by the medical evidence and treating physicians’ recommendations.
Key Takeaways
- A workers’ compensation claim for “unspecified head injury” is broad enough to encompass treatment for headaches resulting from the original trauma, even if the specific mechanism (occipital nerve stimulation) was not explicitly contemplated.
- The opinions of treating physicians carry substantial weight in determining whether proposed medical treatment is reasonable and necessary; conflicting opinions from non-treating physicians do not override them absent clear evidence of unreasonableness.
- Courts review agency decisions on medical necessity using a highly deferential standard and will not overturn them when supported by substantial medical evidence.
Why It Matters
This decision expands the practical scope of workers’ compensation coverage for head injuries by confirming that employers cannot narrowly construe the compensable diagnosis to exclude innovative or emerging treatments recommended by the claimant’s medical team. The case signals that headaches stemming from work-related head trauma are inherently compensable, and employers cannot deny related treatments merely because the condition was not explicitly named in the original claim.
For injured workers, the decision reinforces that treating physicians’ medical judgments about necessary treatment—including advanced interventions like nerve stimulation—will be given serious deference in workers’ compensation disputes, provided the treatment is reasonably related to the compensable injury. The court’s rejection of cherry-picked conflicting opinions from non-treating physicians strengthens the position of workers represented by experienced medical teams.